Work

A phase II study of lonafarnib (SCH66336) in patients with chemo-refractory advanced head and neck squamous cell carcinoma (HNSCC)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.5565

Authors: C. H. Yang, M. S. Kies, B. Glisson, B. J. Burke, L. E. Ginsberg, M. T. Truong, M. M. Sugrue, W. K. Hong, F. R. Khuri, E. S. Kim

Institutions: The University of Texas MD Anderson Cancer Center, Emory University, Winship Cancer Institute

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2222401067

Cites:

Cited by: 18

Related to: 10